Realizing the Promise of Reverse Phase Protein Arrays for Clinical, Translational, and Basic Research: A Workshop Report

被引:128
作者
Akbani, Rehan [1 ]
Becker, Karl-Friedrich [2 ]
Carragher, Neil [3 ]
Goldstein, Ted [4 ]
de Koning, Leanne [5 ]
Korf, Ulrike [6 ]
Liotta, Lance [7 ]
Mills, Gordon B. [1 ]
Nishizuka, Satoshi S. [8 ]
Pawlak, Michael [10 ]
Petricoin, Emanuel F. [7 ]
Pollard, Harvey B. [9 ]
Serrels, Bryan [3 ]
Zhu, Jingchun
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Tech Univ Munich, D-80290 Munich, Germany
[3] Univ Edinburgh, MRC Inst Genet & Mol Med, Edinburgh Canc Res UK Ctr, Edinburgh, Midlothian, Scotland
[4] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA
[5] Inst Curie, Paris, France
[6] German Canc Res Ctr, Heidelberg, Germany
[7] George Mason Univ, Fairfax, VA 22030 USA
[8] Iwate Med Univ, Morioka, Iwate 020, Japan
[9] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[10] Nat & Med Sci Inst, Reutlingen, Germany
关键词
PARAFFIN-EMBEDDED TISSUES; HUMAN BREAST-CANCER; PATHWAY-ACTIVATION; CELL-LINES; MICROARRAY ANALYSIS; PROTEOMIC ANALYSIS; MEMBRANE-PROTEINS; SYSTEMS-ANALYSIS; DRUG DISCOVERY; BIOMARKER;
D O I
10.1074/mcp.O113.034918
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Reverse phase protein array (RPPA) technology introduced a miniaturized "antigen-down" or "dot-blot" immunoassay suitable for quantifying the relative, semi-quantitative or quantitative (if a well-accepted reference standard exists) abundance of total protein levels and post-translational modifications across a variety of biological samples including cultured cells, tissues, and body fluids. The recent evolution of RPPA combined with more sophisticated sample handling, optical detection, quality control, and better quality affinity reagents provides exquisite sensitivity and high sample throughput at a reasonable cost per sample. This facilitates large-scale multiplex analysis of multiple post-translational markers across samples from in vitro, preclinical, or clinical samples. The technical power of RPPA is stimulating the application and widespread adoption of RPPA methods within academic, clinical, and industrial research laboratories. Advances in RPPA technology now offer scientists the opportunity to quantify protein analytes with high precision, sensitivity, throughput, and robustness. As a result, adopters of RPPA technology have recognized critical success factors for useful and maximum exploitation of RPPA technologies, including the following: preservation and optimization of pre-analytical sample quality, application of validated high-affinity and specific antibody (or other protein affinity) detection reagents, dedicated informatics solutions to ensure accurate and robust quantification of protein analytes, and quality-assured procedures and data analysis workflows compatible with application within regulated clinical environments. In 2011, 2012, and 2013, the first three Global RPPA workshops were held in the United States, Europe, and Japan, respectively. These workshops provided an opportunity for RPPA laboratories, vendors, and users to share and discuss results, the latest technology platforms, best practices, and future challenges and opportunities. The outcomes of the workshops included a number of key opportunities to advance the RPPA field and provide added benefit to existing and future participants in the RPPA research community. The purpose of this report is to share and disseminate, as a community, current knowledge and future directions of the RPPA technology.
引用
收藏
页码:1625 / 1643
页数:19
相关论文
共 115 条
[41]   Neuregulin Autocrine Signaling Promotes Self-Renewal of Breast Tumor-Initiating Cells by Triggering HER2/HER3 Activation [J].
Lee, Cleo Yi-Fang ;
Lin, Yuan ;
Bratman, Scott V. ;
Feng, Weiguo ;
Kuo, Angera H. ;
Scheeren, Ferenc A. ;
Engreitz, Jesse M. ;
Varma, Sushama ;
West, Robert B. ;
Diehn, Maximilian .
CANCER RESEARCH, 2014, 74 (01) :341-352
[42]   Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy [J].
Lee, Jonathan A. ;
Uhlik, Mark T. ;
Moxham, Christopher M. ;
Tomandl, Dirk ;
Sall, Daniel J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (10) :4527-4538
[43]   Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks [J].
Lee, Michael J. ;
Ye, Albert S. ;
Gardino, Alexandra K. ;
Heijink, Anne Margriet ;
Sorger, Peter K. ;
MacBeath, Gavin ;
Yaffe, Michael B. .
CELL, 2012, 149 (04) :780-794
[44]  
LEGENDRE N, 1990, Biotechniques, V9, P788
[45]   Protein microarrays: Meeting analytical challenges for clinical applications [J].
Liotta, LA ;
Espina, V ;
Mehta, AI ;
Calvert, V ;
Rosenblatt, K ;
Geho, D ;
Munson, PJ ;
Young, L ;
Wulfkuhle, J ;
Petricoin, EF .
CANCER CELL, 2003, 3 (04) :317-325
[46]   Infrared-based protein detection arrays for quantitative proteomics [J].
Loebke, Christian ;
Sueltmann, Holger ;
Schmidt, Christian ;
Henjes, Frauke ;
Wiemann, Stefan ;
Poustka, Annemarie ;
Korf, Ulrike .
PROTEOMICS, 2007, 7 (04) :558-564
[47]   A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum [J].
Longo, Caterina ;
Gambara, Guido ;
Espina, Virginia ;
Luchini, Alessandra ;
Bishop, Barney ;
Patanarut, Alexis S. ;
Petricoin, Emanuel F., III ;
Beretti, Francesca ;
Ferrari, Barbara ;
Garaci, Enrico ;
De Pol, Anto ;
Pellacani, Giovanni ;
Liotta, Lance A. .
EXPERIMENTAL DERMATOLOGY, 2011, 20 (01) :29-34
[48]   Core-Shell Hydrogel Particles Harvest, Concentrate and Preserve Labile Low Abundance Biomarkers [J].
Longo, Caterina ;
Patanarut, Alexis ;
George, Tony ;
Bishop, Barney ;
Zhou, Weidong ;
Fredolini, Claudia ;
Ross, Mark M. ;
Espina, Virginia ;
Pellacani, Giovanni ;
Petricoin, Emanuel F., III ;
Liotta, Lance A. ;
Luchini, Alessandra .
PLOS ONE, 2009, 4 (03)
[49]   Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling [J].
Lu, Y. ;
Muller, M. ;
Smith, D. ;
Dutta, B. ;
Komurov, K. ;
Iadevaia, S. ;
Ruths, D. ;
Tseng, J-T ;
Yu, S. ;
Yu, Q. ;
Nakhleh, L. ;
Balazsi, G. ;
Donnelly, J. ;
Schurdak, M. ;
Morgan-Lappe, S. ;
Fesik, S. ;
Ram, P. T. ;
Mills, G. B. .
ONCOGENE, 2011, 30 (45) :4567-4577
[50]   AbMiner: A bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies [J].
Major, Sylvia M. ;
Nishizuka, Satoshi ;
Morita, Daisaku ;
Rowland, Rick ;
Sunshine, Margot ;
Shankavaram, Uma ;
Washburn, Frank ;
Asin, Daniel ;
Kouros-Mehr, Hosein ;
Kane, David ;
Weinstein, John N. .
BMC BIOINFORMATICS, 2006, 7 (1)